Loading...

Bausch Health Companies Inc.

BHC•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$5.63
$0.09(1.62%)
U.S. Market opens in NaNh NaNm

Bausch Health Companies Inc. (BHC) Stock Overview

Explore Bausch Health Companies Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio13.30
EPS (TTM)$0.42
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$4.14
3 Months$3.50
1 Year Target$6.82

BHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bausch Health Companies Inc. (BHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.30 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.53%
5-Day Change
-4.66%
1-Month Change
12.73%
3-Month Change
-4.82%
6-Month Change
-9.27%
Year-to-Date (YTD) Change
-19.06%
1-Year Change
2.65%
3-Year Change
-25.60%
5-Year Change
-81.74%
All-Time (Max) Change
1025.00%

Contact Information

https://www.bauschhealth.com
15147446792
2150 St. ElzEar Boulevard West, Laval, QC, H7L 4A8

Company Facts

20,700 Employees
IPO DateMar 29, 1994
CountryCA
Actively Trading

Frequently Asked Questions